Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|November 16, 2005
Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosisBrigitte M T Hougardy, John H Maduro, Ate G J van der Zee, et al.
The American Journal of Pathology|June 5, 2012
'Big'-insulin-like growth factor-II signaling is an autocrine survival pathway in gastrointestinal stromal tumorsBart Rikhof, Winette T A van der Graaf, Albert J H Suurmeijer, et al.
Schizophrenia Research|October 15, 2021
Satisfaction with social connectedness as a predictor for positive and negative symptoms of psychosis: A PHAMOUS studyJelle Sjoerd Vogel, Jojanneke Bruins, Steven de Jong, et al.
International Journal of Oncology|October 9, 2003
Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumoursG Bea A Wisman, Harry Hollema, Marco N Helder, et al.
British Journal of Pharmacology|August 4, 2004
Preclinical characterisation of 111In-DTPA-trastuzumabMarjolijn N Lub-de Hooge, Jos G W Kosterink, Patrick J Perik, et al.
International Journal of Cancer|June 21, 2008
A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explantsBrigitte M T Hougardy, Nathalie Reesink-Peters, Fiona A J van den Heuvel, et al.
Frontiers in Psychiatry|May 1, 2023
Self-stigma and cognitive insight in individuals at ultra-high risk for psychosisBouwina Esther Sportel, Mirjam van Enthoven, Rozanne J M van Donkersgoed, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis inductionJan J Koornstra, Mathilde Jalving, Fleur E M Rijcken, et al.
Cancer Discovery|September 4, 2014
Patient-derived xenograft models: an emerging platform for translational cancer researchManuel Hidalgo, Frederic Amant, Andrew V Biankin, et al.
Neoplasia (New York, N.Y.)|September 25, 2008
Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancerEsther C de Haas, Alessandra di Pietro, Kathryn L Simpson, et al.
Pageof 14